scorecardresearch
Sunday, November 3, 2024
TopicRemdesivir

Topic: Remdesivir

Remdesivir, favipiravir sales zoom to record Rs 1,000 crore in 7 months in Covid year

Indian pharma industry launched 44 new antiviral brands in 2020, against just 10 such launches in 2019. However, total number of new brands saw 40% decline.

Scientists identify Covid drug that’s ‘27.5 times more potent than remdesivir’

A peer-reviewed study in Science journal concluded that the drug plitidepsin had "potent preclinical efficacy" against SARS-CoV-2.

Cipla to experiment with Covid drug remdesivir composition to reduce effect on kidneys

Government's subject expert committee asks Cipla to assess renal toxicity of remdesivir's new formulation through a bioequivalence study as well as clinical trials.

Vaccines are great news, but that doesn’t mean we can ignore therapeutics

Even if vaccines are as effective in the real world as they look in clinical trials, they can’t change the course of the pandemic overnight. We need reinforcements.

India will make Covid vaccine accessible to ‘closest friends’, Shringla says in Nepal

Shringla was speaking after handing over 2,000 vials of anti-virus drug Remdesivir to Nepal's Foreign Minister Pradeep Kumar Gyawali to help it contain the Covid pandemic.

WHO advice on remdesivir is a warning for Covid-19 vaccines

The WHO’s thumbs-down on remdesivir highlights why the FDA has to do more than merely rubber-stamp Covid-19 treatments in the face of heavy White House pressure to move quickly.

Delhi doctors unlikely to follow new WHO advice, say remdesivir works in moderate Covid cases

WHO Friday advised against use of remdesivir for Covid because there’s ‘no evidence’ it improves survival, but doctors say it works on moderately ill patients.

WHO advises against use of remdesivir to treat hospitalised Covid patients

WHO experts say their findings shouldn’t be interpreted to mean remdesivir is ineffective, but that there is no evidence it improves patient-important outcomes.

Remdesivir needs more testing in Covid Solidarity trial before being junked — ICMR-NARI chief

ICMR-NARI is body responsible for conducting WHO Solidarity trial in India, and its director Panda says remdesivir cannot be ruled out as a Covid treatment yet.

Final results of US trial reveal remdesivir could shorten recovery time in Covid patients

The results, published in NEJM, come weeks after WHO's Solidarity Trial concluded that remdesivir had little to no effect on hospitalised Covid patients.

On Camera

As a Hindu Canadian, I am deeply hurt by cancellation of Diwali. My community is now sidelined

Canada faces serious foreign interference issues, but these challenges must not be weaponized to unfairly target friendly and important allies like India.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

Indian firms sanctioned by US didn’t violate laws, says MEA. Hyderabad firm that supplied to Army on list

Among 19 Indian firms sanctioned by US Treasury Dept was Lokesh Machines Ltd accused of coordinating with 'Russian defence procurement agent to import Italy-origin CNC machines'.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.